Literature DB >> 902209

Physiotherapeutic treatment of athletic injuries to the muscle--tendon complex of the leg.

D D Wise.   

Abstract

An overview is presented of the most common soft-tissue injuries of the leg in athletes. A simple classification is made on the basis of cause, location of the injury and severity. These injuries can be classified into direct and indirect types. Direct injuries, which are usually the result of one episode of trauma, can be classified further into three grades of severity. Treatment is based on the severity of the injury and its location in the muscle--tendon complex. Indirect muscle--tendon injuries are the result of repetitive subacute microtrauma to the muscle--tendon complex or injury to the structures associated with muscle function (bursa, tendon sheath or fascia). Appropriate treatment regimens are suggested.

Entities:  

Mesh:

Year:  1977        PMID: 902209      PMCID: PMC1879858     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Clinical survey of Achilles tendinitis in athletes.

Authors:  R P Welsh; J Clodman
Journal:  Can Med Assoc J       Date:  1980-01-26       Impact factor: 8.262

Review 2.  Achilles tendon lesions in sport.

Authors:  J G Williams
Journal:  Sports Med       Date:  1986 Mar-Apr       Impact factor: 11.136

3.  An update on the grading of muscle injuries: a narrative review from clinical to comprehensive systems.

Authors:  Alberto Grassi; Alberto Quaglia; Gian Luigi Canata; Stefano Zaffagnini
Journal:  Joints       Date:  2016-06-13

4.  Hamstring muscle strain injuries: what can we learn from history?

Authors:  Bruce Hamilton
Journal:  Br J Sports Med       Date:  2012-03-29       Impact factor: 13.800

Review 5.  Classification and grading of muscle injuries: a narrative review.

Authors:  Bruce Hamilton; Xavier Valle; Gil Rodas; Luis Til; Ricard Pruna Grive; Josep Antoni Gutierrez Rincon; Johannes L Tol
Journal:  Br J Sports Med       Date:  2014-11-13       Impact factor: 13.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.